If you look at the timeline (post 487 - above), both Hydromorphone (PR) and Phendimetrazine (verbal approval from Diane) took roughly 6 weeks to launch after FDA approvals.
Calculating the time from the API agreement PR on 12/13, I’m expecting Phentermine 15 & 30mg to launch in or around the last week in Jan.

After the commercial launch of Phentermine 15 & 30mg, Naltrexone should be the next to launch (per last CC). Moving forward, I don’t expect Elite to PR FDA approvals, only launches.

It will be the kind of situation where you are driving to work\class in the morning or driving home in the evening, and you get an email from either Dianne or your broker alerting you to any one of the following:

Commercial launch of Phentermine 15mg
Commercial launch of Phentermine 30mg
Commercial launch of Naltrexone 50mg
Commercial launch of Undisclosed Generic
Commercial launch of Undisclosed ANDA
Commercial launch of Hi-tech generic of the 100m branded product. Commercial launch of ANDA\NDA 505b2 product (ELI-216 ART)
The monetization of Elite’s investment in Novel

Did I forget anything?